Rare Disease Genetic Tests Would Get Heightened Scrutiny In Altered Model

Genetic tests for rare diseases would receive a high level of scrutiny under a revised draft model endorsed for further evaluation by the HHS Secretary's Advisory Committee on Genetic Testing Nov. 3.

More from Archive

More from Medtech Insight